References
- Simpson G , Judge DJ . Management of malignant pleural effusion. Respirology 2015;20:169
- Thomas JM , Musani AI . Malignant pleural effusions: a review. Clin Chest Med 2013;34:459–71
- Egan AM , McPhillips D , Sarkar S , Breen DP . Malignant pleural effusion. QJM 2014;107:179–84
- Ruckdeschel JC . Management of malignant pleural effusions. Semin Oncol 1994;22:58–63
- Villena Garrido V , Cases Viedma E , Fernández Villar A , de Pablo Gafas A , Pérez Rodríguez E , Porcel Pérez JM , et al. Recommendations of diagnosis and treatment of pleural effusion Update. Arch Bronconeumol 2014;50:235–49
- Maskell NA , Gleeson FV , Davies RJ . Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326–30
- Shi HZ , Liang QL , Jiang J , Qin XJ , Yang HB . Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 2008;13:518–27
- Liang QL , Shi HZ , Qin XJ , Liang XD , Jiang J , Yang HB . Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008;63:35–41
- Shen YC , Liu MQ , Wan C , Chen L , Wang T , Wen FQ . Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis. Exp Ther Med 2012;3:1072–6
- Economidou F , Margaritopoulos G , Antoniou KM , Siafakas NM . The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med 2010;1:3–7
- Folkman J . Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res 2006;312:594–607
- Skovseth DK , Veuger MJ , Sorensen DR , De Angelis PM , Haraldsen G . Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 2005;105:1044–51
- Whiting PF , Weswood ME , Rutjes AW , Reitsma JB , Bossuyt PN , Kleijnen J . Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006;6:9
- Shen Y , Zhu H , Wan C , Chen L , Wang T , Yang T , Wen F . Can cholesterol be used to distinguish pleural exudates from transudates? evidence from a bivariate meta-analysis. BMC Pulm Med 2014;14:61
- Sumi M , Kagohashi K , Satoh H , Ishikawa H , Funayama Y , Sekizawa K . Endostatin levels in exudative pleural effusions. Lung 2003;181:329–34
- Zhang Y , Li S . Diagnostic value of detecting endostatin levels of pleural effusions for lung cancer (Chinese). Shi Yong Lin Chuang Yi Yao Za Zhi 2006;10:22–4
- Zhou W , Bai M , Jin Y . Diagnostic value of VEGF and endostatin for tuberculous pleural effusion and malignant pleural effusion (Chinese). Zhong Hua Jie He Hu Xi Za Zhi 2008;31:139–40
- Yang Y , Sun X , Qu Y . Diagnostic value of VEGF and endostatin for malignant pleural effusions (Chinese). Zhong Hua Zhong Liu Fang Zhi Za Zhi 2009;16:1312–14
- Zhou WB , Bai M , Jin Y . Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Int J Tuberc Lung Dis 2009;13:381–6
- Li XB , Li BL , Shi GL . Clinical significance of matrix metalloproteinase-9 and endostatin in differential diagnosis of benign and malignant pleural effusion (Chinese). Zhong Hua Jie He Hu Xi Za Zhi 2011;34:310–11
- Zhang Y , Yu LK , Xia N . Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion. Asian Pac J Trop Med 2012;5:239–42
- Li Q , Wang YB , Yang YM . The differential diagnostic value of combined detection of endostatin, carcinoembryonic antigen, and tumor-specific growth factor in benign and malignant pleural effusions (Chinese). Lin Chuang Fei Ke Za Zhi 2013;18:688–9
- Rodriguez-Panadero F , Romero-Romero B . Current and future options for the diagnosis of malignant pleural effusion. Expert Opin Med Diagn 2013;7:275–87
- Chen Y , Liang B , Zhao YJ , Wang SC , Fan YB , Wu GP . Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer. Diagn Cytopathol 2012;40:287–91
- Zhang Y , Yu LK , Lu GJ , Xia N , Xie HY , Hu W , et al. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer. Asian Pac J Cancer Prev 2014;15:8435–40
- Zhao WY , Chen DY , Chen JH , Ji ZN . Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites. Cell Biochem Biophys 2014;70:623–8
- Glas AS , Lijmer JG , Prins MH , Bonsel GJ , Bossuyt PM . The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129–35
- Higgins JP , Thompson SG . Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58